DNase I hypersensitive sites (DHS) that are often, but not always, associated with regulation of transcription, might be indicative of the elements outside the promoter that are involved in controlling the expression of the CFTR gene. Several DHS have been identified across 400 kb of DNA flanking the CFTR gene.
These lie 5Ј to the gene at Ϫ79.5 and Ϫ20.9 kb with respect to the translation start site [7] , in introns 1 [8] , 2, 3, 10, 16, 17a, 18, 20 and 21 [9] and 3Ј to the gene at ϩ5.4, ϩ6.8, ϩ7, ϩ7.4 and ϩ15.6 kb, respective, to the end of translation [10] . The presence of some of these DHS has been found to correlate with the 'tissue-specific' expression of the CFTR gene. The DHS at Ϫ20.9 kb might be involved in transcriptional regulation as a CFTR YAC transgene lacking the site was expressed at 60% lower levels than the wildtype YAC in Caco-2 human colon carcinoma cells [11] . The DHS in intron 1 has been shown to contain a tissue-specific regulatory element and to be necessary for normal CFTR expression in the intestine [12] . Similarly, the DHS in introns 20 and 21 [13] and ϩ15.6 kb [10] are associated with tissue-specific enhancer activity. However, the DHS at Ϫ79.5 kb is probably not involved in regulation of CFTR. A 310-kb YAC carrying the CFTR gene and 58.4 kb of upstream DNA but not the Ϫ79.5-kb DHS [14] and 3Ј flanking DNA at least as far as the ϩ15.6-kb DHS (10) , was shown to give full levels of copy-number dependent expression in human epithelial Caco-2 cells [15] and also to give 'tissuespecific' expression adequate to correct the CF phenotype in CF null mice [16] .
The relatively easy access to the airway epithelium, the previous cloning and characterization of the CFTR gene [3, 17] and the expectation that low levels of its expression could have a clinical benefit [18] make cystic fibrosis an ideal target for gene therapy. Previous experiments with small mini-gene or cDNA constructs that obviously could not cover the whole ~189-kb region of the gene showed some expression of CFTR in transgenic mice [19] [20] [21] [22] [23] [24] and low levels of transient correction in patients [25] [26] [27] [28] [29] [30] . However, such constructs are not expressed sufficiently in the appropriate tissues to achieve clinical improvement in patients. A [15] , in mouse cells [31] and in CF null transgenic mice [16] and also to incorporate and express it from a 5.5 Mb naturally occurring mini-chromosome [32] . However 
large genomic construct spanning ~250 kb including all the known long-range controlling elements of the CFTR gene should give full levels of 'tissue-specific' expression and might be advantageous for gene therapy of cystic fibrosis. A 310-kb YAC genomic construct has previously been used to express the CFTR gene in human cells

Materials and methods
Construction of plasmids
For the modification of BAC 205G13, the pBlSHomABeloHomOSloxZeo vector was constructed (Fig. 1) 
Homologous recombinations
Preparation of electrocompetent EL350 bacteria [33] 
PCR assays for checking recombination events
The following primers were used to check that correct homologous recombinations had occurred as described in the results section and Fig. 1 . CFTR12165: 5ЈTAGTCCATTGTCACATGCCC (12165-12184 of BAC68P20, labelled 3 in Fig. 1 ). [34] , labelled 2 in Fig. 1 [34] , labelled 1 in Fig. 1 [34] , labelled 7 in Fig. 1) . HomAR: 5ЈCAAACTCGAGATTGCACATGGGCACTAACA (13962-13943 of BAC 68P20 [34] , labelled 8 in Fig. 1) . HomBL: 5ЈATTTGGATCCACTGGTTCAGTCAGGTTGGG (21266-21285 of BAC 133K23 [34] , labelled 9 in Fig. 1 ). HomBR: 5ЈATTTGTCGACAACTCAGACCCCGTTCACAC (22558-22539 of BAC 133K23 [34] , labelled 10 in Fig. 1 ). Sp1: 5ЈTTTGCAACTGCGGGTCAAGG [34] , labelled 11 in Fig. 1 
BELO6951: 5ЈGGTTATGTGGACAAAATACCTGG (6874-6951 of pBeloBAC11
BAC DNA preparation and pulsed-field electrophoresis
Small amounts of BAC DNA were prepared from 1.5 ml of saturated culture using a standard alkali miniprep protocol [35] 
RT-PCR
Results
Construction of the human CFTR BAC
Modification of BAC 205G13
The first step of the overall strategy shown in Fig. 1 (Fig. 1) . Zeocin resistant clones were screened by PCR using primers CFTR12165/BELO6951 (labelled 3 and 2 in Fig. 1 ) and CFTR7969/ BELO2658 (labelled 4 and 1 in Fig. 1 Fig. 2 ).
Construction of an oriP/EBNA-1 CFTR BAC vector
For the construction of a BAC vector carrying the human CFTR gene and an oriP/EBNA-1 element, Cre-catalysed homologous recombination targeted at loxP sites was used to retrofit plasmid pRetroNeoOE [36] into the CFTR1, 2, 3 BAC to give BAC CFTR1, 2, 3 OE (Fig. 1) . Clones doubly resistant to spectinomycin and gentamycin were screened by PCR using primers BELO2658 and Sp1 (labelled 1 and 11 in Fig. 1 ) and by PFGE. Twelve correctly retrofitted CFTR1, 2, 3 OE BAC clones were obtained and one of them is shown in Fig. 2 . [31] [39, 40] [37, 38] . Specifically, the E. coli strain BM4573 has been modified to (1) (Fig. 3B) (Fig. 4) We applied homologous recombination in E. coli as previously described [34] and developed plasmids that will be of general use for linking contiguous overlapping BACs. Indeed, our group succeeded in linking two BACs covering the entire factor VIII gene into a single vector using the same system [38] . Another system based on Red recombination has also been devised for linking overlapping BACs [43] , but it cannot be used for linking more than two BACs and is limited as it depends on the presence of only one common restriction site in the overlapping region of the two BACs. For linking more than two BACs, the pBACLinkSp and pBACLinkGm vectors [34] [16, [45] [46] [47] [48] [49] [42, 50, 51] . The extent of exon 9 skipping, in particular, depends on the number of Ts (5, 7 or 9) and of TGs (9-13 repeats) in the exon 9 splice acceptor [52, 53] . The proportion of misspliced variants increases with smaller T alleles (5T) in conjunction with longer TG alleles but was found to differ in cultured cells compared to in vivo observations [54] . In our study in CMT-93 cells, skipping of the first 248 or the first 195 nucleotides of exon 13 , which has been reported previously [42, 55] , was not detected in any of the three F3RC RT-PCR products. Product B was found to contain exon 12, the omission of which has been demonstrated in a significant proportion of transcripts from normal individuals [50] . No 
Assessment of CFTR1, 2, 3 and CFTR1, 2, 3 OE BACs in CMT-93 cells
The expression of the human CFTR gene from BAC CFTR1, 2, 3 was assessed in CMT-93 mouse cells as these cells have previously been found to express the gene
. None of the clones were PCR positive for both regions suggesting rearrangements of the BAC DNA (data not shown). A high frequency of rearrangements has also been observed with three different BACs, all larger than 130 kb in size, when transfected into B16F10 (mouse melanoma, I.J. Fidler, Texas Medical Center, Houston, TX, USA) cells using lipofectamine 2000. These data together suggest that transfection using lipofectamine 2000 is not a good method for delivering large vectors into mammalian cells intact. In contrast, delivery of large BACs intact into mammalian cells using invasive bacteria has proven very successful.
Delivery of CFTR1, 2, 3 and CFTR1, 2, 3 OE BACs into CMT-93 cells by bacterial invasion
Direct delivery of very large BAC DNA into mammalian cells can be achieved by bacterial invasion
express invasin from Yersinia pseudotuberculosis (the inv gene), which binds to ␤1-integrins on mammalian cells leading to internalization, (2) have impaired cell wall synthesis due to DAP auxotrophy which causes lysis after internalization and (3) express listeriolysin O from Listeria monocytogenes (the hly locus), which is a poreforming cytolysin that allows escape from the vacuole after entry. BACs CFTR1, 2, 3 and CFTR1, 2, 3 OE were first electroporated into BM4573 bacteria to generate BMCFTR and BMCFTROE strains, respectively. Subsequently, CMT-93 cells were invaded by BMCFTR and BMCFTROE. Three zeocin-resistant clones were obtained from the invasion by BMCFTR (CMTCF1-3) and 8 neomycin-resistant clones were obtained from invasion by BMCFTROE (CMTCFOE1-9). RT-PCR was performed on all 11 cell lines with the humanspecific primers F1R and 523F that amplify from exon 19 to exon 24 (Fig. 3A). All clones showed expression of the human CFTR mRNA but the levels cannot be determined as the PCR reactions were carried out under saturating conditions. All 11 clones were also analysed by RT-PCR with the h/m2-6 primers [31] that amplify a 610-bp region from exon 2 to exon 6 from both mouse and human mRNA. The origin of the resulting PCR product was determined after restriction enzyme digestion with Nru I
